ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Hot Features

Registration Strip Icon for default Regístrate gratis para obtener cotizaciones en tiempo real, gráficos interactivos, flujo de opciones en vivo y más.

CRMD CorMedix Inc

5.83
0.46 (8.57%)
Fuera de horario
Última actualización: 16:44:17
Retrasado por 15 minutos
Nombre de la Acción Símbolo de la Acción Bolsa de Valores Tipo de Valor
CorMedix Inc CRMD NASDAQ Acción Común
  Variación del Día (ptos.) Variación del Día (%) Último Precio Hora
0.46 8.57% 5.83 16:44:17
Precio de Apertura Precio Mínimo Precio Máximo Precio de cierre Precio Anterior
5.49 5.4305 5.92 5.84 5.37
más cotizaciones de acciones »

Noticias Recientes

Fecha Hora Fuente Noticia
19/4/202407:30GLOBECorMedix Inc. Announces CMS Grants TDAPA to DefenCath
15/4/202407:30GLOBECorMedix Inc. Announces U.S. Inpatient Commercial..
12/3/202406:30GLOBECorMedix Inc. Reports Fourth Quarter and Full Year 2023..
30/1/202416:26EDGAR2Form 8-K - Current report
18/1/202415:53EDGAR2Form 4/A - Statement of changes in beneficial ownership of..
17/1/202419:11EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/1/202419:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/1/202419:09EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/1/202419:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/12/202307:39EDGAR2Form 8-K - Current report
14/12/202315:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/11/202315:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/11/202315:11EDGAR2Form 8-K - Current report
14/11/202315:05GLOBECorMedix Inc. Reports Third Quarter and Nine Month 2023..
30/10/202315:35EDGAR2Form 8-K - Current report
11/10/202307:30GLOBECorMedix Inc. Announces Abstract Presentation at Upcoming..
13/9/202316:25EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
13/9/202316:20EDGAR2Form DEF 14A - Other definitive proxy statements
08/9/202315:21EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/9/202307:30GLOBECorMedix Inc. Announces Publication of Phase 3 LOCK IT-100..
30/8/202307:00GLOBECorMedix Inc. Announces Issuance of U.S. Patent Covering..
17/8/202307:30EDGAR2Form 8-K - Current report
08/8/202307:12EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
08/8/202306:45EDGAR2Form 8-K - Current report
08/8/202306:30GLOBECorMedix Inc. Reports Second Quarter and Six Month 2023..
30/6/202315:40EDGAR2Form 8-K - Current report
30/6/202315:38EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
28/6/202321:57GLOBECorMedix Inc. Announces Pricing of $40 Million Public..
28/6/202316:13EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
28/6/202315:07GLOBECorMedix Inc. Announces Proposed Public Offering of Common..
21/6/202307:30GLOBECorMedix Inc. Announces FDA Acceptance of Resubmission of..
15/6/202307:30GLOBECormedix Inc. Announces Strategic Initiative With Boston..
16/5/202306:00GLOBECorMedix Inc. Announces Resubmission of New Drug Application..
15/5/202315:05GLOBECorMedix Inc. Reports First Quarter 2023 Financial Results..

Su Consulta Reciente

Delayed Upgrade Clock